Home > Products > CD3 & IGF1R
> Recombinant Anti-CD3 x Anti-IGF1R Bispecific Antibody (Tandem scFv)
Recombinant Anti-CD3 x Anti-IGF1R Bispecific Antibody (Tandem scFv) (CAT#: BSFV-092)
Recombinant Anti-CD3 x Anti-IGF1R Bispecific Antibody (Tandem scFv) is designed to be expressed as a scFv from an anti-CD3 antibody variable domains fused with a scFv from an anti-IGF1R antibody variable domains. It contains a His-tag at the C/N terminus for affinity purification. The BsAb exits as monomer in reducing and non-reducing conditions. This BsAb can retarget T cells to tumor cells. It is designed for the research of Melanoma; Colon cancer; Pancreas cancer; Prostate cancer; Kidney cancer therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD3 x Anti-IGF1R Bispecific Antibody (Tandem scFv) (BSFV-092). Click the button below to contact us or submit your feedback about this product.